» Articles » PMID: 36426089

Dataset of Prostate MRI Annotated for Anatomical Zones and Cancer

Abstract

In the present work, we present a publicly available, expert-segmented representative dataset of 158 3.0 Tesla biparametric MRIs [1]. There is an increasing number of studies investigating prostate and prostate carcinoma segmentation using deep learning (DL) with 3D architectures [2], [3], [4], [5], [6], [7]. The development of robust and data-driven DL models for prostate segmentation and assessment is currently limited by the availability of openly available expert-annotated datasets [8], [9], [10]. The dataset contains 3.0 Tesla MRI images of the prostate of patients with suspected prostate cancer. Patients over 50 years of age who had a 3.0 Tesla MRI scan of the prostate that met PI-RADS version 2.1 technical standards were included. All patients received a subsequent biopsy or surgery so that the MRI diagnosis could be verified/matched with the histopathologic diagnosis. For patients who had undergone multiple MRIs, the last MRI, which was less than six months before biopsy/surgery, was included. All patients were examined at a German university hospital (Charité Universitätsmedizin Berlin) between 02/2016 and 01/2020. All MRI were acquired with two 3.0 Tesla MRI scanners (Siemens VIDA and Skyra, Siemens Healthineers, Erlangen, Germany). Axial T2W sequences and axial diffusion-weighted sequences (DWI) with apparent diffusion coefficient maps (ADC) were included in the data set. T2W sequences and ADC maps were annotated by two board-certified radiologists with 6 and 8 years of experience, respectively. For T2W sequences, the central gland (central zone and transitional zone) and peripheral zone were segmented. If areas of suspected prostate cancer (PIRADS score of ≥ 4) were identified on examination, they were segmented in both the T2W sequences and ADC maps. Because restricted diffusion is best seen in DWI images with high b-values, only these images were selected and all images with low b-values were discarded. Data were then anonymized and converted to NIfTI (Neuroimaging Informatics Technology Initiative) format.

Citing Articles

Clinical efficacy of prostate PI-RADS V2.1 score combined with serum PSA-related indicators in the detection of gray zone prostate cancer.

Lin S, Yu X, Chen H, Chen Z, Yang Y Int Urol Nephrol. 2023; 55(11):2685-2693.

PMID: 37523077 DOI: 10.1007/s11255-023-03692-0.

References
1.
Armato 3rd S, Huisman H, Drukker K, Hadjiiski L, Kirby J, Petrick N . PROSTATEx Challenges for computerized classification of prostate lesions from multiparametric magnetic resonance images. J Med Imaging (Bellingham). 2019; 5(4):044501. PMC: 6228312. DOI: 10.1117/1.JMI.5.4.044501. View

2.
Meyer A, Chlebus G, Rak M, Schindele D, Schostak M, van Ginneken B . Anisotropic 3D Multi-Stream CNN for Accurate Prostate Segmentation from Multi-Planar MRI. Comput Methods Programs Biomed. 2020; 200:105821. DOI: 10.1016/j.cmpb.2020.105821. View

3.
Chen J, Wan Z, Zhang J, Li W, Chen Y, Li Y . Medical image segmentation and reconstruction of prostate tumor based on 3D AlexNet. Comput Methods Programs Biomed. 2020; 200:105878. DOI: 10.1016/j.cmpb.2020.105878. View

4.
Adams L, Makowski M, Engel G, Rattunde M, Busch F, Asbach P . Prostate158 - An expert-annotated 3T MRI dataset and algorithm for prostate cancer detection. Comput Biol Med. 2022; 148:105817. DOI: 10.1016/j.compbiomed.2022.105817. View

5.
Fedorov A, Schwier M, Clunie D, Herz C, Pieper S, Kikinis R . An annotated test-retest collection of prostate multiparametric MRI. Sci Data. 2018; 5:180281. PMC: 6278692. DOI: 10.1038/sdata.2018.281. View